
Ravensun Pharmaceuticals Private Limited
About Ravensun Pharmaceuticals Private Limited
Data last updated:
Ravensun Pharmaceuticals Private Limited is a private limited company based in Srinagar, Jammu And Kashmir, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 August 2022.
The company is registered with the Registrar of Companies (ROC), Jammu, under CIN U51909JK2022PTC013692. Its GSTIN is 01AAMCR0885P1ZV (Jammu and Kashmir).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Showket Ahmad Beigh and Zaid Showkat.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C/O Hilal Ahmad Zargar Fateh Kadal, Srinagar, Jammu and Kashmir, India – 190002.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.1 Lakh. For the same year it recorded a net loss of ₹20,800 (net margin -6.7%) and EBITDA of -₹20,800 (EBITDA margin -6.7%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ravensun Pharmaceuticals Private Limited's registered office is in Srinagar, Jammu And Kashmir. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC/O Hilal Ahmad Zargar Fateh Kadal, Srinagar, Jammu and Kashmir, India – 190002
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Ravensun Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ravensun Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ravensun Pharmaceuticals Private Limited, buy the company report.
Financials of Ravensun Pharmaceuticals Private Limited
FY 2024 filings availableRavensun Pharmaceuticals Private Limited reported revenue of ₹3.1 Lakh for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹20,800 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹20,800 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -6.7% | |
| Net Profit Margin | -6.7% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Ravensun Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ravensun Pharmaceuticals Private Limited
Ravensun Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Showket Ahmad Beigh | Director | 05 Aug 2022 | 4 Years 3 Months | Current |
| Zaid Showkat Also directs: Weitz Formulations Private Limited | Director | 05 Aug 2022 | 4 Years 3 Months | Current |
Auditor
Ravensun Pharmaceuticals Private Limited is audited by AMIT MEHRA AND CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AMIT MEHRA AND CO | FY 2023 | 511626 |
Shareholding
The shareholding of Ravensun Pharmaceuticals Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Ravensun Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ravensun Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ravensun Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Ravensun Pharmaceuticals Private Limited has 1 active EPFO establishment as of Nov 12, 2026.
GST
Ravensun Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 01AAMCR0885P1ZV | Jammu and Kashmir | Active | 15 Apr 2024 |
To see the full GST registrations and return filing status of Ravensun Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ravensun Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Showket Ahmad Beigh was appointed as Director on 05 Aug 2022.
Frequently asked questions
Ravensun Pharmaceuticals is an active private limited company based in Srinagar, Jammu And Kashmir, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 August 2022 (4+ years old) and is registered under CIN U51909JK2022PTC013692.
Ravensun Pharmaceuticals has 2 current directors:
- Showket Ahmad Beigh - Director
- Zaid Showkat - Director
The latest financial statements of Ravensun Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Ravensun Pharmaceuticals is 01AAMCR0885P1ZV, registered in Jammu and Kashmir.
The CIN (Corporate Identification Number) of Ravensun Pharmaceuticals is U51909JK2022PTC013692. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ravensun Pharmaceuticals was incorporated on 05 August 2022, making it 4+ years old. It is registered with the Registrar of Companies, Jammu.
Showket Ahmad Beigh was appointed as Director on 05 Aug 2022. Zaid Showkat was appointed as Director on 05 Aug 2022.
The registered office of Ravensun Pharmaceuticals is at CO Hilal Ahmad Zargar Fateh Kadal, Srinagar, Jammu and Kashmir, India – 190002.
Ravensun Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Ravensun Pharmaceuticals is compliant as of 18 July 2026. The company is actively filing with the Registrar of Companies.

